|Bid||64.630 x 100|
|Ask||64.780 x 200|
|Day's Range||64.300 - 64.800|
|52 Week Range||63.880 - 88.850|
|PE Ratio (TTM)||6.84|
|Dividend & Yield||2.08 (3.24%)|
|1y Target Est||N/A|
Valeant and Gilead Sciences' are arguably cheap stocks, but big questions remain that still make them risky to buy.
Amgen may need to do a major acquisition to revive is stock price longterm
Jim Cramer shares his take on caller favorite stocks, including this drugmaker.